Skip to main content
Top
Published in: European Journal of Pediatrics 6/2016

01-06-2016 | Case Report

Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion

Authors: Alkim Oden Akman, Ozge Basaran, Derya Ozyoruk, Unsal Han, Tulin Sayli, Nilgun Cakar

Published in: European Journal of Pediatrics | Issue 6/2016

Login to get access

Abstract

Castleman disease (CD) is a rare poorly understood lymphoproliferative disorder. Pediatric onset CD has been reported before. However, most of them have benign unicentric pattern. Multicentric CD (MCD) is quite rare in children. Herein, we report a 13-year-old adolescent boy with MCD of the hyaline vascular variant presenting with pleural and pericardial effusion, which is an uncommon presentation.
Conclusion: MCD should be considered in the differential diagnosis of pleural and/or pericardial effusion with unexplained lymph nodes in children.
What is Known
Pediatric Castleman disease (CD) most commonly occurs in the unicentric form, which typically is asymptomatic and cured by lymph node excision.
The diagnosis of MCD can be difficult owing to the heterogeneity of presentation and potential for nonspecific multisystem involvement.
What is New
A 13-year-old adolescent boy was diagnosed with MCD of the hyaline vascular variant presenting with pleural and pericardial effusion, which is an uncommon presentation.
In a pediatric patient with fever, pleural-pericardial effusion and multiple lymph nodes, MCD should be considered in differantial diagnosis.
Literature
1.
go back to reference Castleman B, Towne VW (1954) Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot N Engl J Med 251(10):396–400CrossRefPubMed Castleman B, Towne VW (1954) Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot N Engl J Med 251(10):396–400CrossRefPubMed
2.
go back to reference Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM (2012) The clinical spectrum of Castleman’s disease. Am J Hematol 87(11):997–1002CrossRefPubMedPubMedCentral Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM (2012) The clinical spectrum of Castleman’s disease. Am J Hematol 87(11):997–1002CrossRefPubMedPubMedCentral
3.
go back to reference Farruggia P, Trizzino A, Scibetta N, Cecchetto G, Guerrieri P, D’Amore ES, D’Angelo P (2011) Castleman's disease in childhood: report of three cases and review ofthe literature. Ital J Pediatr. 20;37:50 Farruggia P, Trizzino A, Scibetta N, Cecchetto G, Guerrieri P, D’Amore ES, D’Angelo P (2011) Castleman's disease in childhood: report of three cases and review ofthe literature. Ital J Pediatr. 20;37:50
4.
go back to reference Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y (2012) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, Ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima and Nagoya meetings. J Clin Exp Hematop 53(1):57–61CrossRef Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y (2012) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, Ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima and Nagoya meetings. J Clin Exp Hematop 53(1):57–61CrossRef
5.
go back to reference Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, Kobayashi S, Kashimura M, Masawa N, Nakamura S (2011) Multicentric Castleman’s disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus 20(1):44–50CrossRefPubMed Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, Kobayashi S, Kashimura M, Masawa N, Nakamura S (2011) Multicentric Castleman’s disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus 20(1):44–50CrossRefPubMed
6.
go back to reference Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H (2013) Japanese variant of multicentric castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85CrossRefPubMed Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H (2013) Japanese variant of multicentric castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85CrossRefPubMed
7.
go back to reference Parez N, Bader-Meunier B, Roy CC, Dommergues JP (1999) Paediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr 158(8):631–7CrossRefPubMed Parez N, Bader-Meunier B, Roy CC, Dommergues JP (1999) Paediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr 158(8):631–7CrossRefPubMed
8.
go back to reference Smith C, Lee-Miller C, Dishop MK, Cost C, Wang M, Asturias EJ (2014) Multicentric Castleman disease presenting with fever. J Pediatr 165(6):1261–5CrossRefPubMed Smith C, Lee-Miller C, Dishop MK, Cost C, Wang M, Asturias EJ (2014) Multicentric Castleman disease presenting with fever. J Pediatr 165(6):1261–5CrossRefPubMed
9.
go back to reference Soumerai JD, Sohani AR, Abramson JS (2014) Diagnosis and management of Castleman disease. Cancer Control 21(4):266–78PubMed Soumerai JD, Sohani AR, Abramson JS (2014) Diagnosis and management of Castleman disease. Cancer Control 21(4):266–78PubMed
10.
go back to reference Van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin X, Herring J, Casper C, Kurzrock R (2010) Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman’s disease. J Clin Oncol 28(23):3701–8CrossRefPubMed Van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin X, Herring J, Casper C, Kurzrock R (2010) Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman’s disease. J Clin Oncol 28(23):3701–8CrossRefPubMed
Metadata
Title
Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion
Authors
Alkim Oden Akman
Ozge Basaran
Derya Ozyoruk
Unsal Han
Tulin Sayli
Nilgun Cakar
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 6/2016
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-015-2674-6

Other articles of this Issue 6/2016

European Journal of Pediatrics 6/2016 Go to the issue